BIOMAT Database Logo BIOMAT Database Logo

[1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains. 2007

Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Dipartimento Farmaco Chimico Tossicologico, Università degli Studi di Sassari, Via Muroni 23/a, 07100, Sassari, Italy. acarta@uniss.it

In this preliminary study we report the activity of 3-methyl-9-substituted-6-oxo-6,9-dihydro-3H-[1,2,3]-triazolo[4,5-h]quinolone-carboxylic acids and their esters as a new class of antiinfective agents against MDR Mycobacterium tuberculosis. In antitubercular screening against H37Rv and 11 clinically isolated strains of M. tuberculosis several derivatives (1o,3a,c,i,j,p) showed MIC(90) in the range 0.5-3.2 microg/mL. 3c showed no cytotoxicity and proved to be the most potent derivative exhibiting MIC(90)=0.5 microg/mL against all M. tuberculosis strains and infected human macrophages (J774-A1) tested.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone

Related Publications

Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
February 2010, Bioorganic & medicinal chemistry,
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis.
April 2021, ChemMedChem,
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Potent activity against multidrug-resistant Mycobacterium tuberculosis of α-mangostin analogs.
January 2013, Chemical & pharmaceutical bulletin,
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
December 2006, International journal of antimicrobial agents,
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Synthesis of 1,2,3-Triazolo[4,5-h]quinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant Helicobacter pylori.
May 2017, Molecules (Basel, Switzerland),
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Antitubercular agents. Part 2: new thiolactomycin analogues active against Mycobacterium tuberculosis.
April 2005, Bioorganic & medicinal chemistry letters,
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
[Evaluation of new antitubercular agents--new quinolones].
October 1992, Kekkaku : [Tuberculosis],
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Quinolones and multidrug-resistant tuberculosis.
January 1999, Chemotherapy,
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains.
July 2013, Tuberculosis (Edinburgh, Scotland),
Antonio Carta, and Michele Palomba, and Giuseppe Paglietti, and Paola Molicotti, and Bianca Paglietti, and Sara Cannas, and Stefania Zanetti
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
February 2021, European journal of medicinal chemistry,
Copied contents to your clipboard!